CLEAR CELL ENDOMETRIAL CARCINOMA
Clinical trials for CLEAR CELL ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets 'Broken Brakes' in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a drug called valemetostat in people with advanced solid tumors that have certain gene changes (like SMARCB1 or ARID1A). The drug aims to reactivate protective genes to slow or stop cancer growth. About 900 adults will take the drug daily for up to 2 years, with …
Matched conditions: CLEAR CELL ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for aggressive uterine cancer: drug combo targets Obesity-Linked tumors
Disease control Recruiting nowThis early-stage study tests the safety of combining two drugs, atezolizumab and ONC201, for women with advanced or recurrent endometrial cancer. The trial includes both obese and non-obese participants to see how body weight affects treatment. Researchers aim to find the best do…
Matched conditions: CLEAR CELL ENDOMETRIAL CARCINOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 05, 2026 11:53 UTC